Patris Hajrizaj

Advokat (L), Junior Partner

Telephone +45 3333 1103
E-mail ph@buggevalentin.com
LinkedIn

Patris is a seasoned IP expert, advising both Danish and international clients in all matters related to intellectual property rights, trade secrets, marketing practices, and regulatory work. Patris has particular expertise in advising clients in many different sectors such as life sciences and health care, pharmaceuticals, medical devices, food and beverages, automotive, electronics, consumer goods and media & entertainment.

Patris advises on all contentious matters and has substantial experience as a litigator in cases involving patents, SPCs, trade secrets, and trademarks. He has assisted clients in preliminary injunction proceedings, preservation of evidence proceedings, and main actions, including nullity and damages proceedings. Patris also has considerable experience handling matters before the Danish Medicines Agency, the Danish Patents and Trademark Office, and the European Union Intellectual Property Office.

In addition, he works closely with clients on drafting and negotiating commercial contracts, and advises on regulatory matters concerning pharmaceuticals, food products, and marketing – including the legal aspects of advertising medicinal products. Patris is regarded as one of the most promising young IP lawyers of his generation in Denmark.

Career
External Lecturer, University of Copenhagen (Information Technology Law, including IPR)
Advokat, Horten
Assistant Attorney-at-law, Bruun & Hjejle
Right of audience before the Danish High Courts and the Maritime and Commercial Court
Right of audience before the UPC
Admitted to the Danish bar

Education
Master of Laws, the University of Copenhagen
Universität Salzburg, European Private Law – IP Intensive Programme (summer 2015)

Memberships
International Association for the Protection of Intellectual Property (AIPPI)
European Patents Lawyers' Association (EPLAW)
International Trademark Association (INTA)

Languages
English
Albanian
Norwegian
Swedish

Key cases

Bayer v. Sandoz (pharmaceuticals, rivaroxaban, dosage frequence patent), High Court (Eastern Division)

Biogen v. Sandoz (pharmaceutical, dimethyl fumarate, market exclusivity/RDP rights enforcement), High Court (Eastern Division)

Orkla Confectionary and Snacks v the Danish Trademark Appeals Board (3D trademark)

Novartis v. Glenmark (pharmaceuticals, fingolimod, dosage regimen patent, passivity), High Court (Eastern Division)

‘Music artist’ v. ‘music producer’ (copyright, music rights litigation), High Court (Eastern Division)

‘Global skin care brand’ before the Danish Medicines Agency (regarding healthcare claims of skin care products, life sciences regulatory)

Volvo Trucks AB v. Europart Danmark (trademarks, designs, and unfair competition), Aarhus District Court

Novartis v. Zentiva (pharmaceuticals, fingolimod, dosage regimen), High Court (Eastern Division), Winner of the Impact Case of the Year, MANAGING IP 2023

Skechers v. Nuuday, Telia, Telenor et al (internet domains, intermediary liability, trademarks, copyrights, marketing practices, EU law), Maritime and Commercial Court

Orifarm v. Celon Pharma and Glenmark (life sciences regulatory, medical devices, trademarks, marketing practices, EU law), High Court (Eastern Division)

Gilead v. Sandoz (pharmaceuticals, tenofovir disoproxil, SPC), High Court (Eastern Division), repeal of preliminary injunction